Latest Posters

This poster presents a feeder-free protocol that enables scalable differentiation of iPSCs into CD8+ single-positive cytotoxic T cells, offering a robust platform for immunotherapy development.

This poster explores how 6-base whole-genome sequencing of cfDNA boosts the sensitivity of liquid biopsy tests for early cancer detection.

Learn how EpicIF (Enhanced photobleaching in cyclic Immunofluorescence) technology enables the gentle removal of photostable fluorescence signals to enable ultra-high plex immunofluorescence imaging

This poster highlights how IMC technology deciphers the phenotypic and spatial characteristics of brain tumors, providing critical neuro-oncological insights.

This poster evaluates four WTA solutions to determine the best choice for aspects such as library complexity, intra sample concordance and reproducibility.

This poster describes an optimized target enrichment protocol designed to enhance the capture and conversion of fragmented cfDNA for reliable NGS.

This poster highlights how this technology can provide accurate detection of genetic variants and variant-associated methylation in colorectal cancer samples.

This poster highlights the latest spatial biology solutions for GBM tissue analysis, offering critical insights into the metabolic signatures and immune cell infiltration of this tissue type.

Despite the valuable transcriptomic information provided by probe-based spatial assays, detecting immune cell infiltration can pose challenges

Liquid biopsy for profiling of cell free DNA (cfDNA) in blood holds huge promise to transform how we experience and manage cancer by early detection and identification of residual disease and subtype. However, a standard blood draw yields an average of only 10 ng of cfDNA, of which DNA derived from the tumor is a small minority.